Happy July!💙

Greetings, my wonderful healthcare colleagues. We have an abundance of uplifting news to share in this month’s newsletter.

First, Coach Bev shares the opening story from her new book, Healing Through Connection. We meet up with Beverly as she is admitted to the emergency room with syncope, and the nurse demands to know “if she is on drugs or drinking?” Hear more stories at her Virtual Book Release Party on July 23rd. There will be some fun surprises during the launch party too – we hope you can join us!

We’ve updated our Diabetes Med PocketCards for two exciting reasons. There is now a lower dose option for oral semaglutide (Rybelsus) to help reduce side effects and increase tolerability. There is now a new, slightly less expensive, approved version of sitagliptin called Zituvio. Additionally, a lower-cost version of tirzepatide (Zepbound) single-dose vials are now available as a self-pay option.

Our nutrition expert, Christine Craig, explains that despite clear evidence of benefit, people are still under-consuming fruits and vegetables. She shares innovative strategies to close the healthy food gap for people living with diabetes. Dr. Sarah Beattie, our diabetes tech expert, discusses the pros and cons of using the implantable Eversense glucose sensor. You won’t want to miss these articles.

Fantastic Accreditation news. To help you meet your professional CE requirements, we are expanding our Accreditation over the next few months. Our entire course catalog will soon include CE credit through AMA PRA Category 1 Credits™, ACPE, ANCC, and CDR—a big shout-out to Bryanna and our team for their hard work. We are accrediting new courses all the time, so stay tuned!

As always, we encourage you to test your knowledge with our question and rationale of the week.

With wishes for health and moments of joy,

Coach Beverly, Bryanna, Tiffany, Christine, & Katarina